HK Stock MarketDetailed Quotes

BEONE MEDICINES (06160)

Watchlist
  • 174.800
  • -0.300-0.17%
Not Open May 19 16:07 CST
269.44BMarket Cap67.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BEONE MEDICINES (06160) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
35.46%1.51B
40.23%5.34B
43.34%3.84B
44.73%2.43B
48.64%1.12B
54.96%3.81B
47.03%2.68B
61.14%1.68B
67.85%751.65M
73.65%2.46B
Operating income
35.46%1.51B
40.23%5.34B
43.34%3.84B
44.73%2.43B
48.64%1.12B
54.96%3.81B
47.03%2.68B
61.14%1.68B
67.85%751.65M
73.65%2.46B
Cost of sales
-1.34%-167.22M
-12.53%-668.54M
-21.36%-526.12M
-25.29%-329.61M
-32.07%-165M
-56.37%-594.09M
-58.17%-433.53M
-47.97%-263.07M
-52.75%-124.94M
-32.62%-379.92M
Operating expenses
-1.34%-167.22M
-12.53%-668.54M
-21.36%-526.12M
-25.29%-329.61M
-32.07%-165M
-56.37%-594.09M
-58.17%-433.53M
-47.97%-263.07M
-52.75%-124.94M
-32.62%-379.92M
Gross profit
41.37%1.35B
45.34%4.67B
47.57%3.32B
48.33%2.1B
51.95%952.28M
54.71%3.22B
45.06%2.25B
63.85%1.42B
71.23%626.72M
84.06%2.08B
Selling expenses
-20.86%-555.1M
-13.68%-2.08B
-15.07%-1.53B
-14.47%-997.2M
-7.45%-459.29M
-21.42%-1.83B
-21.73%-1.33B
-20.40%-871.16M
-30.12%-427.43M
-18.01%-1.51B
Research and development expenses
-12.31%-541.22M
-9.86%-2.15B
-8.44%-1.53B
-10.02%-1.01B
-4.61%-481.89M
-9.82%-1.95B
-9.86%-1.41B
-10.07%-915.1M
-12.74%-460.64M
-8.42%-1.78B
Operating profit
2,150.96%249.9M
178.69%447.14M
153.62%262.1M
126.86%98.99M
104.25%11.1M
52.95%-568.2M
40.68%-488.77M
46.59%-368.51M
29.60%-261.35M
32.52%-1.21B
Financing income
115.28%27.66M
1.24%70.51M
-69.09%12.37M
-68.20%9.35M
-20.48%12.85M
-5.90%69.64M
-30.67%40.03M
-5.47%29.39M
0.90%16.16M
41.02%74.01M
Financing cost
-369.68%-32.89M
-167.07%-58.23M
----
----
---7M
---21.81M
----
----
----
----
Special items of earning before tax
268.00%14.54M
-236.71%-42.55M
-726.09%-6.86M
218.54%12.12M
124.18%3.95M
-104.10%-12.64M
-99.62%1.1M
77.54%-10.22M
-90.37%1.76M
237.54%307.89M
Earning before tax
1,140.26%259.22M
178.21%416.85M
159.78%267.61M
134.48%120.45M
108.59%20.9M
35.46%-533M
5.77%-447.65M
50.41%-349.35M
27.75%-243.43M
57.89%-825.84M
Tax
-62.29%-31.86M
-16.22%-129.92M
-4.26%-47.18M
-11.93%-24.86M
-154.14%-19.63M
-100.07%-111.79M
-15.77%-45.26M
11.75%-22.21M
32.79%-7.72M
-30.61%-55.87M
After-tax profit from continuing operations
17,802.13%227.36M
144.50%286.93M
144.72%220.43M
125.73%95.59M
100.51%1.27M
26.87%-644.79M
4.13%-492.91M
49.07%-371.56M
27.92%-251.15M
56.00%-881.71M
Earning after tax
17,802.13%227.36M
144.50%286.93M
144.72%220.43M
125.73%95.59M
100.51%1.27M
26.87%-644.79M
4.13%-492.91M
49.07%-371.56M
27.92%-251.15M
56.00%-881.71M
Profit attributable to shareholders
17,802.13%227.36M
144.50%286.93M
144.72%220.43M
125.73%95.59M
100.51%1.27M
26.87%-644.79M
4.13%-492.91M
49.07%-371.56M
27.92%-251.15M
56.00%-881.71M
Basic earnings per share
0.16
142.55%0.2
144.44%0.16
125.93%0.07
0
27.69%-0.47
5.26%-0.36
50.00%-0.27
26.92%-0.19
56.38%-0.65
Diluted earnings per share
0.15
140.43%0.19
141.67%0.15
125.93%0.07
0
-0.47
5.26%-0.36
50.00%-0.27
26.92%-0.19
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
UAS
UAS
UAS
UAS
UAS
UAS
UAS
UAS
UAS
UAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young AG
--
--
--
Ernst & Young AG
--
--
--
Ernst & Young LLP
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 35.46%1.51B40.23%5.34B43.34%3.84B44.73%2.43B48.64%1.12B54.96%3.81B47.03%2.68B61.14%1.68B67.85%751.65M73.65%2.46B
Operating income 35.46%1.51B40.23%5.34B43.34%3.84B44.73%2.43B48.64%1.12B54.96%3.81B47.03%2.68B61.14%1.68B67.85%751.65M73.65%2.46B
Cost of sales -1.34%-167.22M-12.53%-668.54M-21.36%-526.12M-25.29%-329.61M-32.07%-165M-56.37%-594.09M-58.17%-433.53M-47.97%-263.07M-52.75%-124.94M-32.62%-379.92M
Operating expenses -1.34%-167.22M-12.53%-668.54M-21.36%-526.12M-25.29%-329.61M-32.07%-165M-56.37%-594.09M-58.17%-433.53M-47.97%-263.07M-52.75%-124.94M-32.62%-379.92M
Gross profit 41.37%1.35B45.34%4.67B47.57%3.32B48.33%2.1B51.95%952.28M54.71%3.22B45.06%2.25B63.85%1.42B71.23%626.72M84.06%2.08B
Selling expenses -20.86%-555.1M-13.68%-2.08B-15.07%-1.53B-14.47%-997.2M-7.45%-459.29M-21.42%-1.83B-21.73%-1.33B-20.40%-871.16M-30.12%-427.43M-18.01%-1.51B
Research and development expenses -12.31%-541.22M-9.86%-2.15B-8.44%-1.53B-10.02%-1.01B-4.61%-481.89M-9.82%-1.95B-9.86%-1.41B-10.07%-915.1M-12.74%-460.64M-8.42%-1.78B
Operating profit 2,150.96%249.9M178.69%447.14M153.62%262.1M126.86%98.99M104.25%11.1M52.95%-568.2M40.68%-488.77M46.59%-368.51M29.60%-261.35M32.52%-1.21B
Financing income 115.28%27.66M1.24%70.51M-69.09%12.37M-68.20%9.35M-20.48%12.85M-5.90%69.64M-30.67%40.03M-5.47%29.39M0.90%16.16M41.02%74.01M
Financing cost -369.68%-32.89M-167.07%-58.23M-----------7M---21.81M----------------
Special items of earning before tax 268.00%14.54M-236.71%-42.55M-726.09%-6.86M218.54%12.12M124.18%3.95M-104.10%-12.64M-99.62%1.1M77.54%-10.22M-90.37%1.76M237.54%307.89M
Earning before tax 1,140.26%259.22M178.21%416.85M159.78%267.61M134.48%120.45M108.59%20.9M35.46%-533M5.77%-447.65M50.41%-349.35M27.75%-243.43M57.89%-825.84M
Tax -62.29%-31.86M-16.22%-129.92M-4.26%-47.18M-11.93%-24.86M-154.14%-19.63M-100.07%-111.79M-15.77%-45.26M11.75%-22.21M32.79%-7.72M-30.61%-55.87M
After-tax profit from continuing operations 17,802.13%227.36M144.50%286.93M144.72%220.43M125.73%95.59M100.51%1.27M26.87%-644.79M4.13%-492.91M49.07%-371.56M27.92%-251.15M56.00%-881.71M
Earning after tax 17,802.13%227.36M144.50%286.93M144.72%220.43M125.73%95.59M100.51%1.27M26.87%-644.79M4.13%-492.91M49.07%-371.56M27.92%-251.15M56.00%-881.71M
Profit attributable to shareholders 17,802.13%227.36M144.50%286.93M144.72%220.43M125.73%95.59M100.51%1.27M26.87%-644.79M4.13%-492.91M49.07%-371.56M27.92%-251.15M56.00%-881.71M
Basic earnings per share 0.16142.55%0.2144.44%0.16125.93%0.07027.69%-0.475.26%-0.3650.00%-0.2726.92%-0.1956.38%-0.65
Diluted earnings per share 0.15140.43%0.19141.67%0.15125.93%0.070-0.475.26%-0.3650.00%-0.2726.92%-0.19
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards UASUASUASUASUASUASUASUASUASUAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young AG------Ernst & Young AG------Ernst & Young LLP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.54%
Sample Name
Sample Code
 +4.71%
Sample Name
Sample Code
 0.00%
4
SHANGHAI PECHEM
00338
-0.81%
5
SINOPEC CORP
00386
-0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +42.01%
Sample Name
Sample Code
 +32.82%
Sample Name
Sample Code
 +26.86%
4
Emdoor Information
001314
+25.83%
5
Digital China Group
000034
+20.88%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -